BR9603377A - Derivados de sulfonil-ou sulfinilbenzoilguanidina - Google Patents

Derivados de sulfonil-ou sulfinilbenzoilguanidina

Info

Publication number: BR9603377A
Authority: BR; Brazil
Prior art keywords: halo; ch2f; substd; chf2; het
Prior art date: 1995-08-11

Application number

BR9603377A

Other languages

English (en)

Other versions

BR9603377B1 (pt

Inventor

Rolf Dr Gericke

Manfred Dr Baumgarth

Klaus-Otto Dr Minck

Norbert Dr Beier

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-11

Filing date

1996-08-09

Publication date

1998-05-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7769293&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9603377(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-08-09 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

1998-05-12 Publication of BR9603377A publication Critical patent/BR9603377A/pt

2009-01-13 Publication of BR9603377B1 publication Critical patent/BR9603377B1/pt

Links

XOFVXSMENNKBRH-UHFFFAOYSA-N n-[amino-(sulfinylamino)methylidene]benzamide Chemical class O=S=NC(N)=NC(=O)C1=CC=CC=C1 XOFVXSMENNKBRH-UHFFFAOYSA-N 0.000 title 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 5
125000005843 halogen group Chemical group 0.000 abstract 4
JNCMHMUGTWEVOZ-UHFFFAOYSA-N F[CH]F Chemical compound F[CH]F JNCMHMUGTWEVOZ-UHFFFAOYSA-N 0.000 abstract 2
108010081348 HRT1 protein Hairy Proteins 0.000 abstract 2
102100021881 Hairy/enhancer-of-split related with YRPW motif protein 1 Human genes 0.000 abstract 2
125000000753 cycloalkyl group Chemical group 0.000 abstract 2
VUWZPRWSIVNGKG-UHFFFAOYSA-N fluoromethane Chemical compound F[CH2] VUWZPRWSIVNGKG-UHFFFAOYSA-N 0.000 abstract 2
125000005004 perfluoroethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 abstract 2
125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 abstract 1
JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
125000002947 alkylene group Chemical group 0.000 abstract 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
125000004981 cycloalkylmethyl group Chemical group 0.000 abstract 1
DCDPUQNQPMGSTK-UHFFFAOYSA-N n-(diaminomethylidene)-4-sulfinylcyclohexa-1,5-diene-1-carboxamide Chemical compound NC(N)=NC(=O)C1=CCC(=S=O)C=C1 DCDPUQNQPMGSTK-UHFFFAOYSA-N 0.000 abstract 1
125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
125000004430 oxygen atom Chemical group O* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229920006395 saturated elastomer Polymers 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1
125000004434 sulfur atom Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/38—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Vascular Medicine (AREA)
Reproductive Health (AREA)
Pulmonology (AREA)
Gastroenterology & Hepatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Measuring Leads Or Probes (AREA)

BRPI9603377-0A 1995-08-11 1996-08-09 derivados de 4-sulfonil- ou sulfinilbenzoilguanidina e preparaÇço farmacÊutica. BR9603377B1 (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19529612A DE19529612A1 (de)	1995-08-11	1995-08-11	Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate

Publications (2)

Publication Number	Publication Date
BR9603377A true BR9603377A (pt)	1998-05-12
BR9603377B1 BR9603377B1 (pt)	2009-01-13

Family

ID=7769293

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI9603377-0A BR9603377B1 (pt)	1995-08-11	1996-08-09	derivados de 4-sulfonil- ou sulfinilbenzoilguanidina e preparaÇço farmacÊutica.

Country Status (25)

Country	Link
US (1)	US5744641A (pt)
EP (1)	EP0758644B1 (pt)
JP (1)	JP3901766B2 (pt)
KR (1)	KR100447111B1 (pt)
CN (1)	CN1071743C (pt)
AR (1)	AR004677A1 (pt)
AT (1)	ATE252075T1 (pt)
AU (1)	AU709800B2 (pt)
BR (1)	BR9603377B1 (pt)
CA (1)	CA2183050C (pt)
CZ (1)	CZ292974B6 (pt)
DE (2)	DE19529612A1 (pt)
DK (1)	DK0758644T3 (pt)
ES (1)	ES2206534T3 (pt)
HU (1)	HU226134B1 (pt)
MX (1)	MX9603300A (pt)
NO (1)	NO306858B1 (pt)
PL (1)	PL184320B1 (pt)
PT (1)	PT758644E (pt)
RU (1)	RU2159232C2 (pt)
SI (1)	SI0758644T1 (pt)
SK (1)	SK281661B6 (pt)
TW (1)	TW432039B (pt)
UA (1)	UA45965C2 (pt)
ZA (1)	ZA966773B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4328352A1 (de)	1993-08-24	1995-03-02	Hoechst Ag	Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19833118C2 (de)	1998-07-23	2000-07-27	Merck Patent Gmbh	Verfahren zur Herstellung von orthoalkylierten Benzoesäurederivaten
DE19903275A1 (de) *	1999-01-28	2000-08-03	Merck Patent Gmbh	Lyophilisate mit verbesserter Rekonstituierbarkeit
DE19951418A1 (de) *	1999-10-26	2001-05-03	Merck Patent Gmbh	Verfahren zur Herstellung von N-(4,5-Bismethansulfonyl-2-methyl-benzoyl) -guanidin, Hydrochlorid
DE10001879A1 (de)	2000-01-19	2001-07-19	Aventis Pharma Gmbh	Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE10023405A1 (de)	2000-05-12	2001-11-15	Merck Patent Gmbh	Verfahren zur Herstellung von Sulfonyl-benzoylguanidinum-Salzen
KR100643561B1 (ko) *	2000-12-08	2006-11-10	엘지.필립스 엘시디 주식회사	액정표시장치용 어레이기판과 어레이기판의 제조방법
DE10305070A1 (de) *	2003-02-07	2004-08-26	Merck Patent Gmbh	Verwendung von N-(4,5-Methansulfonyl-2-methyl-benzoyl)-guanidin
WO2004099125A1 (de)	2003-05-06	2004-11-18	Merck Patent Gmbh	Verfahren zur kristallisation von guanidinium-salzen
DE102004045825A1 (de) *	2004-09-22	2006-03-23	Merck Patent Gmbh	Lyophilisat enthaltend N-Diaminomethylen-2-methyl-4,5-di-(methylsulfonyl)-benzamid
AU2009243749B2 (en) *	2008-05-09	2013-11-21	Merck Patent Gmbh	Pharmaceutical composition comprising rimeporide for treating diseases associated with insulin resistance and beta-cell dysfunction
BRPI0918502A2 (pt)	2008-09-02	2015-12-01	Sanofi Aventis	aminoindanos substituídos e análogos dos mesmos, e o uso farmacêutico dos mesmos
FR2948028B1 (fr)	2009-07-17	2011-12-02	Merck Sante Sas	Association d'un inhibiteur de l'echangeur sodium-proton et d'un derive amine de dihydro-1,3,5-triazine
CN117304079A (zh)	2016-02-08	2023-12-29	默克专利股份有限公司	N-(4,5-双甲磺酰基-2-甲基苯甲酰基)胍盐酸盐和n-(4,5-双甲磺酰基-2-甲基苯甲酰基)胍盐的结晶变体
EP4230196A1 (en)	2022-02-21	2023-08-23	Som Innovation Biotech, S.A.	Compounds for use in the treatment of dystrophinopathies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU616041B2 (en) *	1988-08-26	1991-10-17	Sumitomo Chemical Company, Limited	A hydrazone compound and production therefor, and an insecticidal composition containing the same
DE3929582A1 (de) *	1989-09-06	1991-03-07	Hoechst Ag	Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DE59305042D1 (de) *	1992-09-22	1997-02-20	Hoechst Ag	Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika
EP0604852A1 (de) *	1992-12-28	1994-07-06	Hoechst Aktiengesellschaft	2,4-Substituierte 5-(N-substituierte-Sulfamoyl)-Benzoylguanidine, als Antiarrythmika, Inhibitoren der Proliferationen von Zellen, und Inhibitoren des Natrium-Protonen-Antiporters
DE4430916A1 (de) *	1994-08-31	1996-03-07	Merck Patent Gmbh	Alkyl-benzoylguanidin-Derivate

1995
- 1995-08-11 DE DE19529612A patent/DE19529612A1/de not_active Withdrawn
1996
- 1996-07-16 TW TW085108613A patent/TW432039B/zh not_active IP Right Cessation
- 1996-08-02 PT PT96112498T patent/PT758644E/pt unknown
- 1996-08-02 EP EP96112498A patent/EP0758644B1/de not_active Expired - Lifetime
- 1996-08-02 DK DK96112498T patent/DK0758644T3/da active
- 1996-08-02 SI SI9630659T patent/SI0758644T1/xx unknown
- 1996-08-02 ES ES96112498T patent/ES2206534T3/es not_active Expired - Lifetime
- 1996-08-02 DE DE59610773T patent/DE59610773D1/de not_active Expired - Lifetime
- 1996-08-02 AT AT96112498T patent/ATE252075T1/de active
- 1996-08-05 CZ CZ19962312A patent/CZ292974B6/cs not_active IP Right Cessation
- 1996-08-05 AU AU61917/96A patent/AU709800B2/en not_active Expired
- 1996-08-07 SK SK1033-96A patent/SK281661B6/sk not_active IP Right Cessation
- 1996-08-08 JP JP22459596A patent/JP3901766B2/ja not_active Expired - Lifetime
- 1996-08-08 ZA ZA9606773A patent/ZA966773B/xx unknown
- 1996-08-08 UA UA96083195A patent/UA45965C2/uk unknown
- 1996-08-09 RU RU96115459/04A patent/RU2159232C2/ru active
- 1996-08-09 KR KR1019960033207A patent/KR100447111B1/ko not_active Expired - Lifetime
- 1996-08-09 NO NO963340A patent/NO306858B1/no not_active IP Right Cessation
- 1996-08-09 AR ARP960103933A patent/AR004677A1/es active IP Right Grant
- 1996-08-09 MX MX9603300A patent/MX9603300A/es unknown
- 1996-08-09 BR BRPI9603377-0A patent/BR9603377B1/pt not_active IP Right Cessation
- 1996-08-09 CA CA002183050A patent/CA2183050C/en not_active Expired - Lifetime
- 1996-08-09 US US08/699,053 patent/US5744641A/en not_active Expired - Lifetime
- 1996-08-09 PL PL96315611A patent/PL184320B1/pl unknown
- 1996-08-09 HU HU9602196A patent/HU226134B1/hu not_active IP Right Cessation
- 1996-08-09 CN CN96109414A patent/CN1071743C/zh not_active Expired - Lifetime

Also Published As

Publication number	Publication date
NO963340L (no)	1997-02-12
NO963340D0 (no)	1996-08-09
ATE252075T1 (de)	2003-11-15
JP3901766B2 (ja)	2007-04-04
EP0758644A1 (de)	1997-02-19
HU226134B1 (en)	2008-05-28
HUP9602196A2 (en)	1997-05-28
ES2206534T3 (es)	2004-05-16
CN1071743C (zh)	2001-09-26
PT758644E (pt)	2004-02-27
PL315611A1 (en)	1997-02-17
TW432039B (en)	2001-05-01
DE19529612A1 (de)	1997-02-13
AU709800B2 (en)	1999-09-09
EP0758644B1 (de)	2003-10-15
MX9603300A (es)	1997-03-29
JPH0952876A (ja)	1997-02-25
US5744641A (en)	1998-04-28
CZ292974B6 (cs)	2004-01-14
SI0758644T1 (en)	2004-04-30
KR970010740A (ko)	1997-03-27
RU2159232C2 (ru)	2000-11-20
AU6191796A (en)	1997-02-13
NO306858B1 (no)	2000-01-03
HU9602196D0 (en)	1996-10-28
HUP9602196A3 (en)	1998-07-28
KR100447111B1 (ko)	2004-12-08
ZA966773B (en)	1997-02-19
CA2183050C (en)	2008-09-30
SK281661B6 (sk)	2001-06-11
CZ231296A3 (en)	1997-02-12
CA2183050A1 (en)	1997-02-12
DK0758644T3 (da)	2003-12-22
AR004677A1 (es)	1999-03-10
UA45965C2 (uk)	2002-05-15
CN1148590A (zh)	1997-04-30
PL184320B1 (pl)	2002-10-31
DE59610773D1 (de)	2003-11-20
BR9603377B1 (pt)	2009-01-13
SK103396A3 (en)	1997-03-05

Legal Events

Date	Code	Title	Description
2002-04-02	FB34	Technical and formal requirements: requirement - article 34 of industrial property law
2005-05-31	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2005-10-04	B09B	Patent application refused [chapter 9.2 patent gazette]	Free format text: INDEFERIMENTO DO PRESENTE PEDIDO COM BASE NO ART. 24 E 25 DA LPI NO 9279 DE 14/05/1996.
2006-01-10	B12B	Appeal against refusal [chapter 12.2 patent gazette]
2007-05-08	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2007-09-18	B09Y	Publication of grant cancelled [chapter 9.1.2 patent gazette]	Free format text: REFERENTE A RPI 1896 DE 08/05/2007.
2009-03-10	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/03/2009, OBSERVADAS AS CONDICOES LEGAIS.
2013-10-08	B22O	Other matters related to patents and certificates of addition of invention: legal action concerning patent	Free format text: INPI-52400.061586/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0132267-10.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG, MERIAL, MONSANTO TECHNOLAGY LLC.
2013-12-17	B21B	Extinction acc. art. 78, item ii - on waiver by the patentee, without prejudice to the rights of third parties	Free format text: SOLICITADA ATRAVES DA PETICAO 860130005242, DE 22/10/2013
2014-12-30	B19A	Notification of judicial decision: notification of judicial decision	Free format text: INPI-52400.061586/13 SECAO JUDICIARIA DO RIO DE JANEIRO - 31A VARA FEDERAL PROCESSO NO 2013.51.01.132267-0 AUTOR INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU(S): MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG, MERIAL E MONSANTO TECHNOLOGY LLC DECISAO: DIANTE DE TODO O EXPOSTO, HOMOLOGO OS ACORDOS RELATIVOS AS PI9505980-6, PI9603377-0 E PI9609387-0, PARA QUE SE PRODUZAM OS EFEITOS LEGAIS E DECLARO EXTINTO O PROCESSO, COM RESOLUCAO DO MERITO, NOS TERMOS DO ART 269, INCISO III, DO CODIGO DE PROCESSO CIVIL, COM RELACAO AS CORRES MONSANTO E MERCK PATENT GMBH.
2020-06-23	B19A	Notification of judicial decision: notification of judicial decision	Free format text: INPI NO 52400.061586/2013-01 31A VARA FEDERAL DO RIO DE JANEIRO NUP: 00408.031526/2020-19 (REF. 0132267-10.2013.4.02.5101) AUTOR: INPI-INSTITUTO NACIONAL DE PROPRIEDADE INDUSTRIAL REU: MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG E OUTROS DECISAO: TRANSITO EM JULGADO EM 15.05.2020, DO ACORDAO FAVORAVEL AO INPI, QUE DEU PROVIMENTO A SUA APELACAO, EM PROCESSO QUE DISCUTE O PRAZO DE VALIDADE DAS PATENTES MAILBOX.

Publication	Publication Date	Title
BR9603377A (pt)	1998-05-12	Derivados de sulfonil-ou sulfinilbenzoilguanidina
EA199901015A1 (ru)	2000-06-26	4"-замещенные производные 9-деоксо-9а-а3а-9а-гомоэритромицина а
PT763534E (pt)	2003-07-31	Arilalquil-diazinonas como inibidores da fosfodiesterase iv
NO305125B1 (no)	1999-04-06	Farmas°ytiske forbindelser
BR9609408A (pt)	1999-07-27	Semicarbazonas tendo atividade cns e preparaç es farmacêuticas contendo as mesmas
DE3776433D1 (de)	1992-03-12	Antimikrobielle mittel.
BR9304763A (pt)	1994-05-24	Composiçao reguladora de crescimento de plantas
NO953404L (no)	1996-03-01	Heterosyklybenzoylguanidiner
EA199800729A1 (ru)	1999-02-25	Производные ациклических нуклеозидов
FR2431531A1 (fr)	1980-02-15	Solutions aqueuses concentrees stables au stockage d'azurants optiques contenant des groupes acide sulfonique
HU9601305D0 (en)	1996-07-29	Fluorine-containing benzoyl-guanidine derivatives
UA43345C2 (uk)	2001-12-17	Похідні 4-меркаптобензоїлгуанідину, спосіб їх отримання, фармацевтична композиція та спосіб її отримання
HU9602331D0 (en)	1996-10-28	Alkenyl-benzoyl-guanidine derivatives
ATE178052T1 (de)	1999-04-15	Alkyl-5-methylsulfonyl-benzoyl-guanidin-derivat
DK0694537T3 (da)	2001-12-03	Heterocyclyloxy-benzoylguanidinderivater, fremstilling deraf og anvendelse deraf som inhibitorer for den cellulære Na+/H+-antiporter
EA200200540A1 (ru)	2002-10-31	Щелочные соли n-(6-алкил-2,4-диоксо-1,2,3,4-тетрагидро-5-пиримидинсульфон)-n'-изоникотиноилгидразида, которые могут обладать антимикробной и иммунотропной активностью, способ их получения, их использование в качестве иммуномодулятора и фармацевтическая композиция на их основе
NO960112L (no)	1996-07-12	3-Alkoksykarbonyltiadiazinoner
EE9600114A (et)	1997-02-17	Asendatud 4H-püraanid
GR3035097T3 (en)	2001-03-30	Acyl substituted aminopyrans with a modulating effect on calcium channels
ES8800885A1 (es)	1987-12-16	Procedimiento mejorado de preparacion de derivados de estireno substituido
ES8707177A1 (es)	1987-08-01	Procedimiento de preparar derivados de estireno substituido
ES8705840A1 (es)	1987-06-01	Procedimiento de preparar derivados de estireno substituido